Clinical Trials Browser

Phase 2 × Advanced Triple-Negative Breast Cancer × Gemcitabine × Clear all

NCT06685796 2024-11-13

A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer

Phase 2 Recruiting

Advanced Triple-Negative Breast Cancer